Neorecormon



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Hepatitis C 66.7%
Anaemia 33.3%
Splenic Rupture 50.0%
Sudden Death 50.0%
Secondary
Drug Use For Unknown Indication 27.4%
Hepatitis C 15.1%
Product Used For Unknown Indication 14.7%
Anaemia 6.9%
Renal Failure Chronic 4.8%
Epilepsy 4.3%
Hypertension 3.0%
Herpes Zoster 2.6%
Prophylaxis 2.5%
Coronary Artery Disease 2.4%
Nephrogenic Anaemia 2.4%
Renal Failure 2.4%
Myelodysplastic Syndrome 2.3%
Pain 1.5%
Depression 1.4%
Hepatitis 1.3%
Breast Cancer Metastatic 1.2%
Hepatitis B 1.2%
Immunosuppression 1.2%
Multiple Myeloma 1.2%
Aplasia Pure Red Cell 29.0%
Urosepsis 16.3%
Drug Effect Decreased 6.5%
Herpes Zoster 6.2%
Myelodysplastic Syndrome 6.2%
Venous Insufficiency 5.4%
Panmyelopathy 3.7%
Thrombocytopenia 3.7%
Haemoglobin Decreased 3.1%
Post Procedural Complication 2.8%
General Physical Health Deterioration 2.5%
Pancytopenia 2.0%
Vomiting 2.0%
Death 1.7%
Hyperkalaemia 1.7%
No Therapeutic Response 1.7%
Anaemia 1.4%
Normochromic Normocytic Anaemia 1.4%
Pyrexia 1.4%
Wegener's Granulomatosis 1.4%
Concomitant
Product Used For Unknown Indication 39.1%
Hepatitis C 13.6%
Drug Use For Unknown Indication 12.5%
Anaemia 6.1%
Hypertension 5.2%
Prophylaxis 4.4%
Hyperparathyroidism Secondary 2.6%
Multiple Myeloma 2.3%
Breast Cancer 1.8%
Renal Transplant 1.7%
Hiv Infection 1.6%
Non-small Cell Lung Cancer 1.6%
Pain 1.5%
Diffuse Large B-cell Lymphoma 1.1%
Renal Failure Chronic 1.0%
Prophylaxis Against Transplant Rejection 0.9%
Chest Pain 0.8%
Hyperparathyroidism 0.7%
Pruritus 0.7%
Hypothyroidism 0.7%
Thrombocytopenia 14.3%
Anaemia 9.8%
Pyrexia 8.2%
Nephrogenic Systemic Fibrosis 6.1%
Vomiting 5.5%
Lung Disorder 4.9%
Rash 4.6%
Cardiac Arrest 4.0%
Death 4.0%
Febrile Neutropenia 4.0%
Renal Failure Acute 4.0%
Swelling 4.0%
Weight Decreased 3.7%
Aplasia Pure Red Cell 3.4%
General Physical Health Deterioration 3.4%
Neutropenia 3.4%
Tachycardia 3.4%
Toxic Epidermal Necrolysis 3.4%
Urinary Tract Infection 3.4%
Pulmonary Embolism 3.0%
Interacting
Hepatitis C 66.7%
Drug Use For Unknown Indication 33.3%
Neutropenia 100.0%